Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Fluid-Screen logo — Fast data you can trust

Fluid-Screen

Fast data you can trust

Founded 2015 United States Beverly, United States 1 employees Series A Total: $10.26M Biotechnology, Health Care +1

General Information

Company Name Fluid-Screen
Founded Year 2015
Location United States Beverly, United States
Employees 1
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Fluid-Screen. To contact Fluid-Screen, visit fluid-screen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Fluid-Screen compare?

A PDF of Fluid-Screen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Fluid-Screen soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Fluid-Screen

Fluid-Screen, a biotechnology and pharmaceutical startup founded in 2014, is at the forefront of revolutionizing bacterial detection with its microchip technology. It offers a solution for rapid and detailed analysis of bacteria in fluid samples within minutes, breaking the traditional time-consuming process that takes days. This innovation not only benefits pharmaceutical companies by accelerating the development and production of new therapies but also has far-reaching implications for industries such as biotherapeutics manufacturing, healthcare, and water quality monitoring. By swiftly detecting and identifying bacterial contamination, Fluid-Screen enables timely, proactive decision-making, ultimately ensuring the safety of products, patients, and customers. The company's latest investment round, a noteworthy $1.17M Series A investment on May 31, 2022, reflects investor confidence in its groundbreaking technology. This capital infusion will likely fuel the startup's efforts to further develop and commercialize its innovative platform, potentially expanding its reach across diverse sectors. Although specific details of the investors involved in this round are not disclosed, the substantial investment indicates a promising future for Fluid-Screen. Overall, Fluid-Screen's disruptive approach to bacterial detection and its recent injection of capital position it as a compelling player in the biotechnology and pharmaceutical industries, poised for continued growth and impact.

Taxonomy: Bacteria Detection, Microchip Technology, Fluid Analysis, Pharmaceutical Industry, Biotherapeutics Manufacturing, Water Quality Monitoring, Real-time Detection, Identification, Diagnostics, Microelectronics, Clean Technology, Lab-on-a-Chip, Rapid Testing, Safety Assurance

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Fluid $1.17M -
31 May 2022
Series A Fluid $1.54M -
30 May 2021
Series A Fluid $5.30M -
20 Jun 2019
Series A Fluid $2.00M 1
Augment Ventures
Augment Ventures
10 Mar 2017
Grant Fluid $150.00K 1
Massachusetts Clean Energy Center
Massachusetts Clean Energy Center
11 Mar 2015
Non Equity Assistance Fluid Undisclosed 1
Cleantech Open
Cleantech Open
01 Jan 2015
Grant Fluid $110.00K 1
MassChallenge
MassChallenge
29 Oct 2014

Fluid-Screen Alternatives & Competitors

View All Alternatives
Fluid-Screen vs
Resistomap
Resistomap Finland

Monitoring today, impacting tomorrow. - Combat antimicrobial resistance using advanced environmental...

Seed
16 employees
Biotechnology, Health Care
Fluid-Screen vs
OmniVis
OmniVis United States

Rapid food borne pathogen detection technology 🦠 Experience the power of the lab in the palm of yo...

Seed
6 employees
Biotechnology, Food and Beverage
Fluid-Screen vs
Quantum-Si
Quantum-Si United States

The Protein Sequencing Company™

IPO
186 employees
Biotechnology, Health Care
View all alternatives

FAQ About Fluid-Screen

Fast data you can trust
Fluid-Screen was founded in 2015.
Fluid-Screen is headquartered in Beverly, United States.
Fluid-Screen operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Bacteria Detection, Microchip Technology, Fluid Analysis and Pharmaceutical Industry.
Fluid-Screen has approximately 1 employees.
Fluid-Screen has completed 7 funding rounds, raising a total of $10.26M. The latest funding stage is Series A.
Top alternatives and competitors to Fluid-Screen include Resistomap, OmniVis, Quantum-Si, Pathogenetix, Inc., bioMérieux. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Fluid-Screen and Resistomap are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Fluid-Screen, https://bouncewatch.com/company/fluid-screen, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes